Biotech Essentials

Startups

Biotech Startups Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Top news of the week: 25.03.2021.

Biotechnology
Cause of action
Allegation
Deception
Federal Bureau of Investigation
North Carolina

Startups

@zbiotech shared
On Mar 18, 2021
RT @adamfeuerstein: SEC charges co-founders of shuttered microbiome startup uBiome with $60 million fraud https://t.co/TgtGy7D16x via @erbrod
Open
SEC charges co-founders of shuttered microbiome startup uBiome with $60 million fraud

SEC charges co-founders of shuttered microbiome startup uBiome with $60 million fraud

The SEC alleged uBiome's co-founders touted the its work "while hiding the fact that the company's purported success depended on deceit."

@big4bio shared
On Mar 22, 2021
.@FierceBiotech has drawn up a list of 2020's biggest money raisers from the #biotech industry. @evaluatepharma https://t.co/jxxKr0Hpe4
Open
Biotech's top 10 money raisers of 2020

Biotech's top 10 money raisers of 2020

Private biopharma companies raised nearly $20 billion in 2020, blowing past the record $17.9 billion set in 2018. Here are the top 10 fundraising rounds, which include some "truly ...

@BiotechWorld shared
On Mar 24, 2021
Zimmermann replaces ex-Roche pRED chief as Inotrem CEO https://t.co/RVH2BgM5S1 https://t.co/XB6eesL5Ie
Open
Zimmermann replaces ex-Roche pRED chief as Inotrem CEO

Zimmermann replaces ex-Roche pRED chief as Inotrem CEO

Inotrem has named Sven Zimmermann as CEO. Zimmermann joins the inflammatory disease biotech after overseeing a series of deals at former employers including Novimmune’s asset sale to Sobi ...

@ForbesTech shared
On Mar 18, 2021
SEC charges microbiome startup uBiome's cofounders with defrauding investors for $60 million https://t.co/35E9VG9Dnu by @TheAlexKnapp napp
Open
SEC Charges Microbiome Startup uBiome’s Cofounders With Defrauding Investors For $60 Million

SEC Charges Microbiome Startup uBiome’s Cofounders With Defrauding Investors For $60 Million

Jessica Richman and Zachary Apte were charged Thursday for failing to disclose significant issues related to the company's insurance billing practices.

@ForbesTech shared
On Mar 19, 2021
RT @Forbes: A federal grand jury indicts uBiome's cofounders on criminal fraud charges https://t.co/Qhq8rUzLNu by @TheAlexKnapp https://t.co/0rRbc3xxB2
Open
Federal Grand Jury Indicts uBiome Cofounders On Criminal Fraud Charges

Federal Grand Jury Indicts uBiome Cofounders On Criminal Fraud Charges

On Thursday, a Federal grand jury indicted biotech startup uBiome’s cofounders Jessica Richman and Michael Apte with multiple charges related to defrauding insurance companies and investors.

@FiercePharma shared
On Mar 18, 2021
Fujifilm takes its CDMO power play to the Tarheel State with plans for $2B plant https://t.co/dL2KFEtn13
Open
Fujifilm takes its CDMO power play to the Tarheel State with plans for $2B plant

Fujifilm takes its CDMO power play to the Tarheel State with plans for $2B plant

In Holly Springs, North Carolina, Fujifilm will invest more than $2 billion to build the largest cell culture biopharmaceutical CDMO facility in North America. 

@GENbio shared
On Mar 19, 2021
. @FujifilmDiosyn Plans $2B Cell Culture Facility in Holly Springs, NC. What will the facility contain? https://t.co/Erz8pnW6bz https://t.co/0SANZUe4uq
Open
Fujifilm Diosynth Plans $2B Cell Culture Facility in Holly Springs, NC

Fujifilm Diosynth Plans $2B Cell Culture Facility in Holly Springs, NC

Two months after announcing plans to build a $2 billion cell culture manufacturing facility in the United States, Fujifilm has finally revealed the location—Holly Springs, NC, a 25-minute ...

@BusinessInsider shared
On Mar 24, 2021
The former scientific head of Trump's vaccine push is facing a sexual harassment claim from his time at pharma giant GSK https://t.co/fsmVHLuLy2
Open
The former scientific head of Trump's vaccine push is facing a sexual-harassment claim from his time at pharma giant GSK

The former scientific head of Trump's vaccine push is facing a sexual-harassment claim from his time at pharma giant GSK

GSK said that it had substantiated the allegations against Moncef Slaoui and that the investigation is ongoing.